| | 
Part, Chapter, Paragraph
1 II, 5. 5. 3| Dev 19:379-387.~Eriksson KJ., Koivikko MJ (1997): Prevalence,
2 II, 5. 5. 3| Surveillance (1998): In: Rothman KJ, Greenland S (eds). Modern
3 II, 5. 6. 6| Chambers LW, Badley EM, Bennett KJ, Goldsmith CH, Jamieson
4 II, 5. 7. 7| 20;141(2):95-101.~Jager KJ, van Dijk PC (2007): Has
5 II, 5. 7. 7| Transplant 2007;22:678-80.~Jager KJ, Zoccali C (2007): Clinical
6 II, 5. 7. 7| Billon S, van Dijk PC, Jager KJ, Dekker FW, Simpson K, et
7 III, 10. 1. 3| 71-86.~Kushner MG, Sher KJ, Beitman BD (1990): The
8 III, 10. 2. 1| Kelly S, Brown T, Campbell KJ (2005): Interventions for
9 IV, 11. 6. 5| Publishers, Inc., 1997~ ~Rothman KJ, Greenland, eds. Modern
|
|
| |